Business Context and Reporting Period
Company: IGC Pharma, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 30, 2023
Event: Entry into a Material Definitive Agreement (Master Loan and Security Agreement).
Key Financial Metrics
This filing reports on a new financing arrangement rather than periodic operating results. Specific metrics include:
- Debt Capacity: Up to USD $12,000,000.00 under the new Credit Facility.
- Interest Rate: Certificate of Deposit rate plus a 1% margin.
- Upfront Costs: USD $120,000.00 facility fee paid at closing.
- Use of Proceeds: Working capital needs and general corporate purposes.
- Liquidity: The filing does not provide current cash balances or liquidity ratios.
Material Changes
The primary material change is the establishment of a new revolving credit facility with O-Bank, CO., LTD. (Taiwan). This represents a new direct financial obligation and an increase in available borrowing capacity compared to the prior period, though the filing does not quantify the company's total debt prior to this transaction.
Outlook, Risks, and Contingencies
- Maturity: The facility matures on the first anniversary of the Effective Date (June 30, 2024).
- Default Provisions: The agreement contains customary events of default. Upon default, the Lender may require immediate payment of all outstanding amounts.
- Management Commentary: The filing states funds are for working capital and general corporate purposes as deemed necessary by IGC.
- Risks: The company is subject to the covenants and repayment obligations of the Loan Agreement.
Investor Verification Checklist
- Verify the full text of the Master Loan Agreement (Exhibit 10.1) for specific covenants and default triggers.
- Confirm the actual drawdown amount, as the $12 million represents the maximum facility limit, not necessarily the amount borrowed.
- Review recent 10-Q or 10-K filings to assess the company's current cash position and ability to service the new debt.
- Check for any subsequent filings regarding the utilization of the credit facility.